"We have brought on board an industry expert in the pharmaceutical sector,
a 15-year former partner who specialized in pharmaceutical consulting at
the Boston Consulting Group".
"Together with the Company's executives has already kicked off the process,
which will lead us to the completion of a long-term strategic growth plan. We
will be working hard in the first half of 2017 fully studying the business
transformation options available to us and anticipate sharing the key pillars
of our long-term growth strategy in the second half of the year".
"While I remain excited about the long-term potential, I reiterate that in the
near-term we remain focused on business stabilization".